- PR Newswire•3 days ago
NanoViricides CEO Dr. Seymour to Present an Update on the Company at The Planet Microcap Showcase - 2017 in Las Vegas; Company Says it is Close to Declaring a Clinical Candidate for the Treatment of Shingles
SHELTON, Conn., April 26, 2017 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), reports that Eugene Seymour, MD, MPH, CEO, will present information about the Company and its progress towards human trials at the Planet Microcap conference at the Planet Hollywood Hotel. NanoViricides, Inc. is a global leader developing antiviral nanomedicines for the treatment of a number of different viral infections. The Company is currently focused on developing its broad spectrum anti-herpesvirus drug candidates.
- PR Newswire•2 months ago
SHELTON, Conn., Feb. 16, 2017 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), filed its quarterly report for its second quarter of financial year 2017 in a timely manner with the Securities and Exchange Commission on Tuesday, February 14th. NanoViricides reported that it had approximately $19.44 Million (M) of current assets (cash, cash equivalents, and prepaid expenses) as of December 31, 2016, the end of the reporting period. The net cash used in operating activities during this quarter was approximately $2.6 M. The Company's research and development (R&D) expenditure has increased as we advance towards human clinical trials.
- Associated Press•2 months ago
On a per-share basis, the Shelton, Connecticut-based company said it had a loss of 3 cents. Losses, adjusted for non-recurring gains, were 4 cents per share. The company's shares closed at $1.17. A year ...
NNVC : Summary for NanoViricides, Inc. NEW - Yahoo Finance
NanoViricides, Inc. (NNVC)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Bid||1.15 x 1000|
|Ask||1.25 x 800|
|Day's Range||1.22 - 1.29|
|52 Week Range||1.03 - 2.04|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-6.15|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|